Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2000 Dec 1;352(Pt 2):549–556.

Prosaposin: promoter analysis and central-nervous-system-preferential elements for expression in vivo.

Y Sun 1, P Jin 1, D P Witte 1, G A Grabowski 1
PMCID: PMC1221488  PMID: 11085950

Abstract

The expression of prosaposin is temporally and spatially regulated at the transcriptional and post-translational levels. In vitro, the mouse prosaposin promoter contains functional RORE [retinoic acid-receptor-related orphan receptor alpha subunit (RORalpha)-binding element], Sp1 and U (unknown) sites within 310 bp directly 5' to the transcription start site and additional elements within 2400 bp 5' to the transcription start site. To elucidate promoter regions important to tissue-preferential expression in vivo, transgenic mice were created with 5'-flanking deletions of the prosaposin gene fused to a luciferase reporter. Nearly exclusive expression was observed in cerebrum, cerebellum and eyes of adult transgenic mice containing constructs with 234-310 bp of 5'-flanking DNA. This central nervous system (CNS) expression was due to the presence of RORE and overlapping Sp1 sites in this region. Internal deletion of RORE and the Sp1 cluster from the longer constructs with 2400 bp of 5'-flanking DNA significantly diminished expression in the CNS. The appearance of substantial visceral tissue (e.g. liver, spleen, lung, kidney, thymus and heart) expression was obtained with transgenic mice bearing constructs with 742-2400 bp of 5'-flanking DNA. The cellular localization of luciferase reporter-gene expression from these constructs corresponded closely with that for prosaposin. These results define important CNS and visceral regulatory regions in the promoter in vivo and may be sufficient to account for the majority of prosaposin's tissue-preferential expression.

Full Text

The Full Text of this article is available as a PDF (289.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chang B. D., Watanabe K., Broude E. V., Fang J., Poole J. C., Kalinichenko T. V., Roninson I. B. Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4291–4296. doi: 10.1073/pnas.97.8.4291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Collard M. W., Sylvester S. R., Tsuruta J. K., Griswold M. D. Biosynthesis and molecular cloning of sulfated glycoprotein 1 secreted by rat Sertoli cells: sequence similarity with the 70-kilodalton precursor to sulfatide/GM1 activator. Biochemistry. 1988 Jun 14;27(12):4557–4564. doi: 10.1021/bi00412a050. [DOI] [PubMed] [Google Scholar]
  3. Dobie K., Mehtali M., McClenaghan M., Lathe R. Variegated gene expression in mice. Trends Genet. 1997 Apr;13(4):127–130. doi: 10.1016/s0168-9525(97)01097-4. [DOI] [PubMed] [Google Scholar]
  4. Fujita N., Suzuki K., Vanier M. T., Popko B., Maeda N., Klein A., Henseler M., Sandhoff K., Nakayasu H., Suzuki K. Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids. Hum Mol Genet. 1996 Jun;5(6):711–725. doi: 10.1093/hmg/5.6.711. [DOI] [PubMed] [Google Scholar]
  5. Harzer K., Paton B. C., Poulos A., Kustermann-Kuhn B., Roggendorf W., Grisar T., Popp M. Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses. Eur J Pediatr. 1989 Oct;149(1):31–39. doi: 10.1007/BF02024331. [DOI] [PubMed] [Google Scholar]
  6. Hermo L., Morales C., Oko R. Immunocytochemical localization of sulfated glycoprotein-1 (SGP-1) and identification of its transcripts in epithelial cells of the extratesticular duct system of the rat. Anat Rec. 1992 Mar;232(3):401–422. doi: 10.1002/ar.1092320310. [DOI] [PubMed] [Google Scholar]
  7. Holtschmidt H., Sandhoff K., Fürst W., Kwon H. Y., Schnabel D., Suzuki K. The organization of the gene for the human cerebroside sulfate activator protein. FEBS Lett. 1991 Mar 25;280(2):267–270. doi: 10.1016/0014-5793(91)80308-p. [DOI] [PubMed] [Google Scholar]
  8. Holtschmidt H., Sandhoff K., Kwon H. Y., Harzer K., Nakano T., Suzuki K. Sulfatide activator protein. Alternative splicing that generates three mRNAs and a newly found mutation responsible for a clinical disease. J Biol Chem. 1991 Apr 25;266(12):7556–7560. [PubMed] [Google Scholar]
  9. Jensen N. A., Pedersen K. M., Celis J. E., West M. J. Neurological disturbances, premature lethality, and central myelination deficiency in transgenic mice overexpressing the homeo domain transcription factor Oct-6. J Clin Invest. 1998 Mar 15;101(6):1292–1299. doi: 10.1172/JCI1807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jin P., Sun Y., Grabowski G. A. Role of Sp proteins and RORalpha in transcription regulation of murine prosaposin. J Biol Chem. 1998 May 22;273(21):13208–13216. doi: 10.1074/jbc.273.21.13208. [DOI] [PubMed] [Google Scholar]
  11. Kishimoto Y., Hiraiwa M., O'Brien J. S. Saposins: structure, function, distribution, and molecular genetics. J Lipid Res. 1992 Sep;33(9):1255–1267. [PubMed] [Google Scholar]
  12. Kotani Y., Matsuda S., Sakanaka M., Kondoh K., Ueno S., Sano A. Prosaposin facilitates sciatic nerve regeneration in vivo. J Neurochem. 1996 May;66(5):2019–2025. doi: 10.1046/j.1471-4159.1996.66052019.x. [DOI] [PubMed] [Google Scholar]
  13. Leonova T., Qi X., Bencosme A., Ponce E., Sun Y., Grabowski G. A. Proteolytic processing patterns of prosaposin in insect and mammalian cells. J Biol Chem. 1996 Jul 19;271(29):17312–17320. doi: 10.1074/jbc.271.29.17312. [DOI] [PubMed] [Google Scholar]
  14. O'Brien J. S., Carson G. S., Seo H. C., Hiraiwa M., Kishimoto Y. Identification of prosaposin as a neurotrophic factor. Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9593–9596. doi: 10.1073/pnas.91.20.9593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. O'Brien J. S., Carson G. S., Seo H. C., Hiraiwa M., Weiler S., Tomich J. M., Barranger J. A., Kahn M., Azuma N., Kishimoto Y. Identification of the neurotrophic factor sequence of prosaposin. FASEB J. 1995 May;9(8):681–685. doi: 10.1096/fasebj.9.8.7768361. [DOI] [PubMed] [Google Scholar]
  16. Paton B. C., Schmid B., Kustermann-Kuhn B., Poulos A., Harzer K. Additional biochemical findings in a patient and fetal sibling with a genetic defect in the sphingolipid activator protein (SAP) precursor, prosaposin. Evidence for a deficiency in SAP-1 and for a normal lysosomal neuraminidase. Biochem J. 1992 Jul 15;285(Pt 2):481–488. doi: 10.1042/bj2850481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Qi X., Kondoh K., Krusling D., Kelso G. J., Leonova T., Grabowski G. A. Conformational and amino acid residue requirements for the saposin C neuritogenic effect. Biochemistry. 1999 May 11;38(19):6284–6291. doi: 10.1021/bi990079o. [DOI] [PubMed] [Google Scholar]
  18. Qi X., Qin W., Sun Y., Kondoh K., Grabowski G. A. Functional organization of saposin C. Definition of the neurotrophic and acid beta-glucosidase activation regions. J Biol Chem. 1996 Mar 22;271(12):6874–6880. doi: 10.1074/jbc.271.12.6874. [DOI] [PubMed] [Google Scholar]
  19. Rafi M. A., de Gala G., Zhang X. L., Wenger D. A. Mutational analysis in a patient with a variant form of Gaucher disease caused by SAP-2 deficiency. Somat Cell Mol Genet. 1993 Jan;19(1):1–7. doi: 10.1007/BF01233949. [DOI] [PubMed] [Google Scholar]
  20. Rorman E. G., Grabowski G. A. Molecular cloning of a human co-beta-glucosidase cDNA: evidence that four sphingolipid hydrolase activator proteins are encoded by single genes in humans and rats. Genomics. 1989 Oct;5(3):486–492. doi: 10.1016/0888-7543(89)90014-1. [DOI] [PubMed] [Google Scholar]
  21. Schnabel D., Schröder M., Sandhoff K. Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease. FEBS Lett. 1991 Jun 17;284(1):57–59. doi: 10.1016/0014-5793(91)80760-z. [DOI] [PubMed] [Google Scholar]
  22. Schonemann M. D., Ryan A. K., McEvilly R. J., O'Connell S. M., Arias C. A., Kalla K. A., Li P., Sawchenko P. E., Rosenfeld M. G. Development and survival of the endocrine hypothalamus and posterior pituitary gland requires the neuronal POU domain factor Brn-2. Genes Dev. 1995 Dec 15;9(24):3122–3135. doi: 10.1101/gad.9.24.3122. [DOI] [PubMed] [Google Scholar]
  23. Sprecher-Levy H., Orr-Urtreger A., Lonai P., Horowitz M. Murine prosaposin: expression in the reproductive system of a gene implicated in human genetic diseases. Cell Mol Biol (Noisy-le-grand) 1993 May;39(3):287–299. [PubMed] [Google Scholar]
  24. Sun Y., Jin P., Grabowski G. A. The mouse prosaposin locus: promoter organization. DNA Cell Biol. 1997 Jan;16(1):23–34. doi: 10.1089/dna.1997.16.23. [DOI] [PubMed] [Google Scholar]
  25. Sun Y., Jin P., Witte D. P., Grabowski G. A. Isolation and characterization of the human prosaposin promoter. Gene. 1998 Sep 18;218(1-2):37–47. doi: 10.1016/s0378-1119(98)00391-6. [DOI] [PubMed] [Google Scholar]
  26. Sun Y., Witte D. P., Grabowski G. A. Developmental and tissue-specific expression of prosaposin mRNA in murine tissues. Am J Pathol. 1994 Dec;145(6):1390–1398. [PMC free article] [PubMed] [Google Scholar]
  27. Zhang X. L., Rafi M. A., DeGala G., Wenger D. A. Insertion in the mRNA of a metachromatic leukodystrophy patient with sphingolipid activator protein-1 deficiency. Proc Natl Acad Sci U S A. 1990 Feb;87(4):1426–1430. doi: 10.1073/pnas.87.4.1426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Zhao Q., Hay N., Morales C. R. Structural analysis of the mouse prosaposin (SGP-1) gene reveals the presence of an exon that is alternatively spliced in transcribed mRNAs. Mol Reprod Dev. 1997 Sep;48(1):1–8. doi: 10.1002/(SICI)1098-2795(199709)48:1<1::AID-MRD1>3.0.CO;2-N. [DOI] [PubMed] [Google Scholar]
  29. Zhao Q., Morales C. R. Identification of a novel sequence involved in lysosomal sorting of the sphingolipid activator protein prosaposin. J Biol Chem. 2000 Aug 11;275(32):24829–24839. doi: 10.1074/jbc.M003497200. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES